{"name":"LAPIX Therapeutics Inc.","slug":"lapix-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxOU3hfa0JPVU9zTXZWc1A0WkRUYVhLZlB3c1RPc1FxVU1mSFBlN0lQT0tOMHlvbXJwRlZMbFhxdV9zTkxfWXBkUFdGcWZaQkFRMHpNMWFvUGpTVjlHZzluYXp4QXI5TlJrT0NXR2JwMGFrd3hZeFdyUzVuR0NuZnVuSkEzdjRRUEFqWXhPUjhsRXBEeUFIZl9jLVc1VVoyaHRmWFRVTWw0S3pFOV9xMlYzU2RpR2ZEV1dieWpjRTd4eElFY2V6UkdhdWNOd0NUUXk1Um95SjhVNHRRRUxXNGtzc2d4a2NkcjN3YmlUWEZCWTlkc2U4YlNyMW50XzFzdw?oc=5","date":"2026-02-16","type":"trial","source":"Investing News Network","summary":"IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Investing News Network","headline":"IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxPeXRZaGk3RTZOeHpINmdIVTZFel9qSk9BbnRwd19YQ2Z6RTF0VktXbHVDX1ByMDdqQ0Q4TkF6WmhPbW96ZXhxSmFJbEU2QWFDOWxSU1RQLTA4cUJ4U2FXNHFrZTgzYU5ra1Y4dEk2cVlhYjhIeXpBWEp2N3BLOWU1WWVSX25kdndOOUdNRC1wYnFsX1dlOS0tQlpHVnRmc3RPOFJaME1TUDBmZFJRU09rLU13RnJWSTY0UkdKSWt6cGtiNHBzX3VwSFdMMUFRWFZ2amJ4Wlh3SEpXb1FNYldxTXoxRnZmb0EzWXU2X00tNHlvdWlteF91N01rUWVVZjlWYkRyTm5vbDlHaWxZQlBiQ2p4VQ?oc=5","date":"2025-11-10","type":"pipeline","source":"GlobeNewswire","summary":"Food Allergy Market Valued at USD 3 Billion across the 7MM, - GlobeNewswire","headline":"Food Allergy Market Valued at USD 3 Billion across the 7MM,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPTHVwSmRyZExBenR5NnlyLTVWNHdCd1RKT3BOR0ZFMHRfWW8wd1NVc3BSMlVEbFdLUUg3QkFtcEhlQXYwQ0gwMUNvdlFRU0c5N3NGZkJuTFR2cTNrT3lyOWRlVWM2NVBMXzNrYlYtUkEyWVVWMDhKdmx5eXNkRS03VlVoUlRWaG9iaVFjRF9sb3NTQVpmRnNwXzhtbVZ5UlktSWt1SWY3cHBFY2hOaExvRno1TF8xNnBacDFhMkxxWWRmNW44M0RTRkFjT05PVzNsb091QUhaV244ME1WeEg1eVNVc29ZMUgzMS11QlZJU1ZESDFnMndDcGlxbkt4ejlGRFNhRlpJMXFzV2RSOXZjejhfTXlnbHJobWxjdWxpVmloVFhtWlVUbEV3?oc=5","date":"2025-09-29","type":"trial","source":"GlobeNewswire","summary":"Peanut Allergy Clinical Trial Pipeline: Insights into a - GlobeNewswire","headline":"Peanut Allergy Clinical Trial Pipeline: Insights into a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPM1VqMkd4bW15LW1RM1FTNFEzNHktNWRhM2hXWUpmMkMtRnc0dEdnaUVoYm1lMEpEQlVQSjJZN2M2ZVd5RmNVRUhmTmpvc2k5eFFaZXQycUdONVVkQ0tucGJYNXJOajY1ZE9tczVIZUp5cUZhMjFWaUpSV2ptclN4ZGl6NmVidXc1ZmU0MzYxTUVfWUZveTVzOS16YXpXaUNVS0V6TUM5dFQwT1huMjRnYnJtQWdwMjNxLTNiMUQtSW1odlNFNWREbGY0Q0JvR2ZuZ2ZQajYxazVxQ1BXdnYwamZONEJ0RkNha1M1NGF1djZlZ0NKVGhiVG50RQ?oc=5","date":"2024-11-19","type":"pipeline","source":"prnewswire.com","summary":"Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight - prnewswire.com","headline":"Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNYVZGb1d4SlV6bHhTQ0RSVURidk9lekxZR0JyZlM1OEFCcmNBcnpaNGZCZzdybERwZFNjb2VSSjJmWXJpdUMwbWMxZW93ZXY0SV8wUDRBSVRaaFRxeFpPNXFCZ3JqQUpwbEtWdFNEY2lPYURISVF2QmV4aG8zdmw0dlpxV0RFT3VnV29fRmdkdDd3WkVrM1VJaU5rb0J3aHdGbkhGeE0yRFM4clBOQWxGT0JaTFcxS3VlVHZzNHU1YjlhQlEtcG1OUjlzdEp1QjU5RlNBeXNlcHZJLVl6SVBONkdkTQ?oc=5","date":"2024-11-13","type":"pipeline","source":"prnewswire.com","summary":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight - prnewswire.com","headline":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}